Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lawrence J. Hineline currently holds 29 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence J. Hineline has been a net seller of ITCI stock. They have purchased $0 and sold $35.8M worth of shares.
Lawrence J. Hineline's most recent insider trade was on Mar 11, 2024, when they sold 1,100 shares at $66.54 per share.
Lawrence J. Hineline serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 141 insider transactions totaling $35.8M over their tenure at the company.
Lawrence J. Hineline holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Lawrence J. Hineline has shown a selling trading pattern, with $0 in total purchases and $35.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lawrence J. Hineline was on Jun 14, 2023, when they sold $2.8M worth of ITCI shares. This transaction involved 44,035 shares at $64.37 per share.
Lawrence J. Hineline currently owns 29 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lawrence J. Hineline's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence J. Hineline has 141 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Lawrence J. Hineline and 40,000+ other insiders.